Streptomycin-Injeel

Streptomycin-Injeel
D 12, D 30, D 200 0.367 ml each.
Streptomycin-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

Streptomycin belongs to the group of aminoglycoside antibiotics. The Indications include, in addition to Gram negative cocci and bacteria, above all the tubercle bacilli. Contraindications for all aminoglycoside antibiotics are serious cardiogenic and nephrogenic secretory disorders. As side effects of this group of antibiotics, the following should be mentioned: renal damage, neuromuscular blockages, paresthesia, muscular pains. In addition to the nephrotoxic properties of streptomycin, allergic reactions are known, i.e. in the form of urticarial eczema and generalized exfoliative dermatitis. Also liver damage and granulorytopenia after the administration of streptomycin are regarded as allergic. Above all, however, streptomycin is neurotoxic, with special affinity to the eighth cerebral nerve. In this connection streptomycin has a special affinity to the vestibular function (symptoms of vertigo, disturbances of equilibrium and gait), while dihydrostreptomycin has a special affinity to the cochlear function (hearing impairment extending to dysacousis and deafness). Cochlear damage, contrary to vestibular disturbance, is practically always irreversible.

Indications

The above-mentioned clinical pictures, in particular symptoms of vertigo, disturbances of equilibrium and gait, but also hearing impairment such as tinnitus aurium, dysacousis and deafness, as also streptomycin, and not only dihydrostreptomycin, can bring about acoustical and cochlear disturbances.